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Abstract 
Objective: We examined the nature of verbal memory deficits and the possible hippocampal 
underpinnings in long-term adult survivors of childhood brain tumor. Method: 35 survivors 
(M=24.10±4.93 years at testing; 54% female), on average 15 years post-diagnosis, and 59 
typically developing adults (M=22.40±4.35 years, 54% female) participated. Automated FMRIB 
Software Library (FSL) tools were used to measure hippocampal, putamen, and whole brain 
volumes. The California Verbal Learning Test – Second Edition (CVLT-II) was used to assess 
verbal memory. Results: Hippocampal (F(1,91)=4.06, ηp2=.04), putamen (F(1,91)=11.18, 
ηp
2
=.11), and whole brain (F(1,92)=18.51, ηp2=.17) volumes were significantly lower for 
survivors than controls (p<.05). Hippocampus and putamen volumes were significantly 
correlated (r=.62, p<.001) with each other, but not with total brain volume (r=.09; r=.08), for 
survivors and controls. Verbal memory indices of auditory attention list span (Trial 1) (F 
(1,92)=12.70, η2=.12) and final list learning (Trial 5) (F (1,92)=6.01, η2=.06) were significantly 
lower for survivors (p<.05). Total hippocampal volume in survivors was significantly correlated 
(r=.43, p=.01) with auditory attention, but none of the other CVLT-II indices. Secondary 
analyses for the effect of treatment factors are presented. Conclusion: Volumetric differences 
between survivors and controls exist for the whole brain and for subcortical structures on average 
15 years post-diagnosis. Treatment factors seem to have a unique effect on subcortical structures. 
Memory differences between survivors and controls are largely contingent upon auditory 
attention list span. Only hippocampal volume is associated with the auditory attention list span 
component of verbal memory. These findings are particularly robust for survivors treated with 
radiation.  
Key words: memory, brain tumor survivorship, long-term, volumetrics, hippocampus 
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Hippocampal Volume and Auditory Attention on a Verbal Memory Task with 
Adult Survivors of Pediatric Brain Tumor 
Higher brain tumor survival rates, achieved over the past several decades, have led to 
increased interest and research on quality of survivorship (Ris, 2007). Extant research has shown 
that a wide range of neuropsychological domains are negatively impacted in pediatric brain 
tumor survivors (Edelstein et al., 2011; Maddrey et al., 2005; Reimers et al., 2003). Within 
neuropsychological domains, pediatric brain tumor survivors have specific deficits in the domain 
of memory (Dennis et al., 1991; Edelstein et al., 2011; Ellenberg et al., 2009; Nagel et al., 2006; 
Winqvist, Vainionpaa, Kokkonen, & Lanning, 2001). The nature of these memory deficits is an 
important area of study because deficits in memory could contribute to learning difficulties in 
school (Edelstein et al., 2011; Gimenez et al., 2004); the rate of information acquisition during 
these formative years is dependent, at least in part, on underlying memory abilities. Furthermore, 
if neuropsychological impairment in the domain of memory continues into adulthood, it could 
impact survivors’ adaptive functioning at the work place, in interpersonal relationships, and in 
daily living activities. Thus, there is a need to further our understanding of memory abilities in 
adult survivors of pediatric brain tumor.  
Verbal memory is defined as the ability to learn, retain, and recall verbal items or words. 
Many survivorship studies have reported on verbal memory abilities following brain tumor 
diagnosis and treatment, but findings are mixed with regard to the specific memory profile 
observed. In one adult brain tumor study, free recall of a word list was negatively affected 
(Armstrong, Stern, & Corn, 2001). Similarly, in two childhood brain tumor studies, one study 
showed that free recall and recognition were significantly poorer in survivors compared to 
controls (Nagel et al., 2006), and another showed that list learning and delayed list recall were 
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impaired (King et al., 2004). In addition, child survivors have been shown to have retrieval 
deficits (Micklewright, King, Morris, & Morris, 2007) and significantly impaired auditory 
attention. The inconsistencies in the specific nature of verbal memory difficulties seen in 
survivors are not surprising given the differences in study samples. Samples were different with 
regard to developmental stage (i.e., child, adult), as well as tumor type and location (e.g., low-
grade supratentorial, third ventricle, cerebellar, medulloblastoma). Moreover, differences in the 
memory tests used also could be contributing to the mixed findings (see Helmstaedter, 2013; 
Loring et al., 2008; for varying sensitivity and specificity of different memory tests). As such, 
whether the memory profile in adult survivors of pediatric brain tumor would show poor 
encoding, retention, or retrieval is difficult to predict based solely on the extant verbal memory 
literature.  
Furthermore, there is a large gap in the brain tumor literature with regard to long-term 
outcomes because most research on survivors takes place within the first 5-10 years following 
treatment. In a past review paper on long-term neurobehavioral outcomes for pediatric brain 
tumor patients (Ris & Noll, 1994) most of the memory studies reporting problems were short-
term (i.e., survivors were on average 4 years or less post-diagnosis), which precluded exploration 
of long-term sequelae. Although two newer studies reported neurocognitive impairments that 
extended into adulthood (Edelstein et al., 2011; Ellenberg et al., 2009), there are methodological 
limitations. For one of these studies the results were based on self-report measures, not objective 
neuropsychological test performance (Ellenberg et al., 2009). For the other study, results were 
based on a composite score derived from analogous measures across different tests or tests 
versions (Edelstein et al., 2011), which is psychometrically problematic. In two long-term studies 
of pediatric brain tumor survivors, one with a heterogeneous sample of tumors (5-10 years after 
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diagnosis) and another with only posterior fossa tumors (2-18 years after diagnosis), cognitive 
dysfunction and significant memory problems were reported (Lannering, Marky, Lundberg, & 
Olsson, 1990; Steinlin et al., 2003). However, these two long-term studies were limited, in that 
most of their participants were children at the time of testing, despite relatively long-term follow-
up. Thus, while many studies have demonstrated a high risk for memory impairment during 
childhood, none have examined cognitive sequelae in young adults more than a decade past 
diagnosis and treatment, using objective neuropsychological performance measures.  
From a developmental standpoint, pediatric brain tumor survivors are diagnosed and 
treated when the brain and memory systems are maturing. The presence and removal of a tumor 
may impact not only the memory systems that are already in place, but also the systems that have 
yet to develop. Therefore, short-term outcomes from childhood studies preclude an 
understanding of adult patterns of verbal memory abilities. Long-term research allows the 
exploration of how adult memory function is affected by pediatric brain tumor.   
A comprehensive picture of verbal memory in adult survivors of pediatric brain tumor 
also requires an understanding of the underlying brain structures that support verbal memory 
function. Verbal memory is a type of declarative memory that is highly dependent on the 
integrity of the hippocampus and other anatomically related structures (Squire, 1992). Many 
studies in patient populations as varied as Alzheimer’s disease (Libon et al., 1998), ischemic 
vascular dementia (Libon et al., 1998), adults with temporal lobe epilepsy with adolescent onset 
(Reminger et al., 2004), combat veterans with and without PTSD (Tischler et al., 2006), elderly 
women (Ystad et al., 2009), and adolescents with a history of prematurity (Gimenez et al., 2004), 
have established a link between hippocampal volume and verbal memory.  
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Research on typically aging adults and aging adults with neurodegenerative diseases 
(e.g., Alzheimer disease) shows that hippocampus related pathology is associated with an 
encoding deficit profile (Carlesimo & Oscar-Berman, 1992; Fernandez et al., 1998), whereas 
non-hippocampus related pathology (e.g., white matter disease) is associated with a retrieval 
deficit profile (Libon et al., 1998; Tierney et al., 2001; Van Petten et al., 2004). An encoding 
deficit profile is characterized by deficits in free recall and recognition, whereas a retrieval 
deficit profile is marked by deficits in free recall but intact recognition. Two neuroimaging 
studies have reported structural differences in hippocampal regions in childhood brain tumor 
survivors (Nagel et al., 2004; Riggs et al., 2014). The Riggs et al. (2014) study also reported 
reductions in global white matter volume and damage to the uncinate fasciculus. Neither of these 
studies examined profiles of memory performance. Riggs and colleagues reported a general 
memory index on a small subset of their sample and Nagel et al (2004) did not provide any 
performance measures. Yet, in a separate study without neuroimaging, Nagel et al. (2006) 
reported predominantly encoding deficits evidenced by impairments in both retrieval and 
recognition on a child list learning test. Even so, memory performance profiles in adult survivors 
of pediatric brain tumor and research on the related underlying hippocampal volumes is a critical 
next step. As the hippocampus is a critical structure supporting verbal memory function, the 
current study focuses on examining hippocampal volume and verbal memory profiles in a 
survivorship sample that is on average 15 years past diagnosis and treatment.  
Before proceeding with such an examination it is important to highlight what is known 
about typical and atypical hippocampal development, as memory systems and hippocampal 
structures were developing when the survivors were diagnosed with brain tumors and underwent 
treatment. Studies of neurotypical children have shown increases in volume of the hippocampus 
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and other temporal gray matter structures, as well as increases in temporal cortex white matter 
integrity, during childhood and adolescence (Mabbott, Rovet, Noseworthy, Smith, & Rockel, 
2009; Utsunomiya, Takano, Okazaki, & Mitsudome, 1999). Utsunomiya, Takano, Okazaki, and 
Mitsudome (1999) studied volumes of the hippocampal formation in 42 children aged 3 weeks to 
14 years. Their results suggest that the volume of the hippocampal formation across their sample 
increased sharply until the age of two, at which point the volume increase became much slower. 
In addition, the results of Benes, Turtle, Khan, and Farol (1994) suggest that typical hippocampal 
development continues into early adulthood.   
The potential for injury to the hippocampus during these early developmental stages, as a 
result of the presence of a brain tumor, its surgical removal, and related treatments, has been 
examined by only two neuroimaging studies. A 5-year longitudinal study of 25 newly diagnosed 
childhood medulloblastoma survivors (mean age at diagnosis = 8 years) evidenced hippocampal 
volume decline for the initial 2 years post-diagnosis (Nagel et al., 2004). These volume declines 
were observed over the course of 6 magnetic resonance imaging (MRI) scans, with the first scan 
taking place at 0.31 years (mean) after diagnosis. The study showed that a normal positive 
growth pattern resumed after the initial 2 years. However, the study was not designed to address 
whether atypical hippocampal development in the early years was ultimately compensated for by 
return to normal growth in later life. Furthermore, the study did not have a control group to 
compare how the hippocampal volume changed over a 2-year time span in healthy children of 
the same age. Building on the study by Nagel et al. (2004), a recent study of children with 
posterior fossa tumors showed that survivors exhibited a smaller right hippocampus compared to 
controls, an average of 5 years post-diagnosis (Riggs et al., 2014). However, the study focused 
mainly on the pathophysiology of memory structures and did not examine the memory profile of 
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the entire sample of children. A subset of their sample (n=10) underwent neuropsychological 
testing, and only the General Memory Index scores are reported. As such, how the hippocampus 
may have related to specific memory deficits is not clear. Furthermore, no data were available on 
comparisons of verbal memory outcomes between the survivors and healthy controls. Therefore, 
in the current study we set out to extend the neuroimaging investigations of Nagel et al. (2004) 
and Riggs et al. (2014) by examining the long-term developmental outcomes (average time since 
diagnosis = 15 years) of not only the hippocampus, but also the verbal memory abilities that it is 
believed to support. 
We also chose to examine another subcortical control brain structure, the putamen, as a 
comparison region, because it is not believed to have a significant influence on verbal memory 
functioning. Total brain volume also was investigated to determine whether treatment-mediated 
volume changes uniformly affect the whole brain or have a particularly negative impact on the 
hippocampus. Examining a subcortical comparison region was important because some research 
suggests that the hippocampus is neurofunctionally unique (i.e., structure, function, potential for 
plasticity), and therefore particularly susceptible to insult compared to other brain areas (Araujo 
& Lapchak, 1994; Franklin, Parmentier-Bateur, Walter, Greendberg, & Stella, 2003; Williamson 
& Bilbo, 2013). Brain-derived neurotropic factor (BDNF) plasticity in the hippocampal 
formation renders it vulnerable to damage and also modulates neuron survival and apoptosis 
(Murray & Holmes, 2011). Also, putative accounts of putamen function suggest that it is 
involved in the procedural and not declarative (e.g., verbal memory) memory system. As such, 
including the putamen as a contrast region in our study increased the specificity of hippocampus 
and verbal memory associations. Furthermore, correcting for total brain volume when examining 
between group differences in subcortical structure volumes allowed us to address whether these 
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structures are uniquely susceptible to damage or whether they mimic the entire brain’s lower 
volume relative to controls.  
The first aim of our study was to examine the differences between adult survivors of 
pediatric brain tumor and neurotypical controls in the volume of the hippocampus, putamen, and 
total brain using magnetic resonance imaging (MRI). It was predicted that survivors would 
exhibit smaller hippocampal and total brain volumes as compared to neurotypical adults. 
Moreover, we examined whether the size of the hippocampus would be different between the 
two groups after controlling for total brain size. Based on research that the hippocampus is 
particularly susceptible, it was hypothesized that hippocampal volume differences would persist 
after controlling for total brain size.   
The second aim was to examine whether treatment affected performance on a 
standardized test of learning and memory. It was predicted that survivors’ learning performance, 
delayed free recall, and delayed recognition memory would be lower when compared to healthy 
controls. In other words, it was likely that survivors would show problems with encoding and 
retrieval, i.e., an encoding deficit memory profile.  
 The third aim was to examine whether or not the hippocampus was associated with 
performance on verbal learning and memory. We predicted that hippocampal volume would be 
significantly correlated with learning and memory, whereas putamen and whole brain volume 
would not be correlated with learning and memory.  
 An important consideration in studies of memory outcomes for brain tumor survivors is 
the complex influence of medical variables because of their known effects on cognitive function. 
These include, but are not limited to, presence of radiation, chemotherapy, endocrine 
dysfunction, and history of hydrocephalus. Therefore, it is important to examine treatment and 
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medical complication variables within the study’s survivor sample. Although the limited sample 
size makes it impossible to address all potential medical factors by methodologically controlling 
for each in the study design, detailed descriptive information is presented regarding these 
variables and the implications are discussed. In addition, we conducted secondary analyses 
within the survivor group for each of the aims and also examined the cumulative effect of 
treatment variables on brain volumes. Furthermore, information about memory performance for 
the radiation treatment and no radiation treatment subgroups in our survivor sample and effect 
sizes and means for these subgroups are presented.  
Method 
Participants 
All participants provided written informed consent and the study protocol was approved 
by the Institutional Review Boards. The sample of participants (N=94) consisted of long-term 
adult survivors of childhood brain tumors (n=35) and demographically matched healthy controls 
(n=59). Survivors were recruited through large mailings: (1) to individuals who participated, as 
children, in a longitudinal study at the time of diagnosis, (2) through the Brain Tumor 
Foundation of Georgia newsletter, and (3) to survivors treated at Children’s Health Care of 
Atlanta, a large south eastern hospital system over 10 years ago. For detailed information about 
survivor recruitment, please refer to the Appendix. Survivors were on average 15.4 years past 
their date of diagnosis. Healthy controls were recruited through the undergraduate Psychology 
participant pool at a large public south eastern university (Georgia State University (GSU)), a 
research imaging center (the GSU/GA Tech Joint Center for Advanced Brain Imaging), friends 
HIPPOCAMPAL VOLUME AND AUDITORY ATTENTION                                                 11 
 
of survivors, and community fliers. Of the 59 control group participants, 48 (i.e., 81%) were 
college students.  
Control group participants were not significantly different from the survivor group with 
regard to sex, age, socioeconomic status (SES), or financial independence. In the final sample of 
participants, survivors (54% female) had a mean age of 24.10 ± 4.93 years and controls (54% 
female) had a mean age of 22.40 ± 4.35 years at the time of study participation. The 
Hollingshead Four Factor Index of Social Status (Hollingshead, 1975) was used to estimate SES 
of each participant. Family SES was used for cases where the individual was considered 
financially dependent and individual SES was used for cases in which the individual was 
independent. Fifty-one percent of the survivor sample and sixty-one percent of the control 
sample was identified as financially dependent. Furthermore, the ethnic diversity of the control 
sample was representative of the state census. For detailed demographic characteristics of 
controls and survivors, see Table 1. Survivors were on average 8.17 ± 4.43 years old at diagnosis 
and an average of 15.38 ± 5.34 years has passed since their diagnosis. Two of the survivors in 
our sample had recurrences and their scores on all dependent variables, age at recurrence, and 
years since recurrence (6.58 for one survivor and 10.50 for the other) were not outliers nor 
appreciably different from the rest of our survivor sample.  
Participants were considered ineligible and excluded from the current study if they did 
not indicate fluency in English, met diagnostic criteria for a pervasive developmental disorder, 
indicated a diagnosis of Neurofibromatosis, or had experienced any other significant 
neurological insult (e.g., traumatic brain injury, stroke). They also were considered ineligible if 
they did not pass the hearing screening and were not using a hearing aid. For healthy controls, 
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there were additional exclusion criteria based on a Structured Clinical Interview of the DSM-IV 
(SCID) Axis I Disorders.   
For all of our aims, we chose to combine the group of survivors who had received 
radiation therapy (n=16) with the group of survivors who had not (n=19) for two reasons: (1) it is 
possible to have memory deficits even in the absence of radiation therapy, as shown by some of 
the literature (see Ellenberg et al., 2009; King et al., 2004; Lannering et al., 1990; Micklewright 
et al., 2007; Steinlin et al., 2003); (2) it is important to examine non-radiotherapy survivors as 
hippocampus development may also be affected by the tumor, brain surgery, and diagnostic 
variables including but not limited to hydrocephalus history and chemotherapy. In addition, we 
conducted secondary analyses to compare the radiotherapy and non-radiotherapy subgroups. 
More information about these secondary analyses follows in the Study Design and Analyses 
section. 
Measures 
Neuroimaging parameters. A Siemens Trio 3T scanner with a standard head coil for 
radiofrequency transmission was used to collect all images. Participants were outfitted with 
protective earplugs to reduce scanner noise. We acquired high-resolution (1.0 mm x 1.0 mm x 
1.0 mm) T1-weighted structural images of the brain by collecting 176 contiguous (i.e. no gap and 
sharing a common border) sagittal slices. A 3D magnetization prepared rapid gradient echo 
imaging (3D MPRAGE) sequence was used with the following parameters: acquisition matrix = 
256 x 256, repetition time (TR) = 2,250 ms, echo time (TE) = 3.98 ms, field of view (FOV) = 
256 mm, slice thickness = 1.0 mm, flip angle = 9o.  
Hippocampal volume. Segmentation and volumetric analysis of the hippocampus was 
performed with FMRIB’s Integrated Registration and Segmentation Tool (FIRST) (see 
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Patenaude, Smith, Kennedy, & Jenkinson, 2011). FIRST is a model-based registration and 
segmentation tool in FSL 4.0 (Smith et al., 2004). The shape and appearance models used in 
FIRST are constructed from manually segmented images provided by the Center for 
Morphometric Analysis (CMA), MGH, Boston (see Patenaude et al., 2011). During registration, 
the input 3D T1 image data were transformed to the MNI 152 standard space by means of affine 
transformations based on 12 degrees of freedom. After registration, a sub-cortical mask was 
applied to locate the hippocampus, followed by segmentation based on shape models and voxel 
intensities. The hippocampus included the dentate gyrus, the ammonic subfields (CA1–4), the 
prosubiculum, and the subiculum; it did not include the fimbria/fornix behind the posterior 
commissure. FIRST has been successfully used to obtain total hippocampal volume by other 
published empirical studies (see de Jong et al., 2008; O’Dwyer et al., 2012; Turner, Furey, 
Drvets, Zarate, & Nugent, 2012). We visually checked the hippocampal segmentations for errors, 
and no errors were noted. The volume of each participant’s left and right hippocampus was 
measured in mm3, and the sum of these two values yielded Total Hippocampal Volume values 
to be used in all subsequent analyses. See Figure 1a for a sample FIRST segmentation of the left 
and right hippocampus. 
Putamen volume. We acquired putamen volumes using the same methods and software 
as that used to obtain hippocampal volume. As the metabolic needs and function of the putamen 
are different from the hippocampus, we used the putamen as a control structure. See Figure 1b 
for a sample FIRST segmentation of the left and right putamen. 
Brain volume. We performed segmentation and volumetric analysis of the whole brain 
using the FMRIB tool SIENAX, which is a part of FSL. SIENAX is a package that estimates 
total brain tissue volume from a single image normalized for skull size (Smith et al., 2002; Smith 
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et al., 2004). SIENAX starts by extracting brain and skull images from the single whole-head 
input data. The brain image is then affine-registered to MNI 152 space. Estimates of total brain 
volume included white matter and grey matter volumes; they did not include CSF. We visually 
checked the whole brain segmentations for errors, and errors were noted for 3 survivors whose 
data were excluded from the study analyses. The volume of each participant’s brain was 
measured in mm3. 
California Verbal Learning Test – Second Edition (CVLT-II). The CVLT-II (Delis, 
Kramer, Kaplan, & Ober, 2000) is an individually administered assessment tool that measures 
several aspects of verbal memory. It has adequate reliability and validity overall, with internal 
consistency estimates usually in the range of .80 or higher (Delis et al., 2000; Hubley, 2004). The 
CVLT-II has been shown to predict residual brain damage in various psychiatric and 
neurological populations (Alexander, Stuss, & Fansabedian, 2003; Delis et al., 2000).  
During the test, the experimenter verbally presents a list of 16 words and asks the 
participant to immediately recall as many items as they can. This is done for 5 consecutive trials. 
The CVLT-II generates multiple memory performance indices, a few of which were selected for 
the current study: (1) The Trial 1 score is the number of items learned and recalled after the first 
presentation of the word list and is thought to indicate auditory attention and short-term memory 
span. (2) The Trial 5 score is the number of items learned and recalled after five repeated 
presentations of the word list. (3) Following a delay period of 20 minutes after the initial learning 
trials, participants are again asked to recall as many items as possible. The Long Delay Free 
Recall (LDFR) score indicates the total number of items recalled after this 20 minute delay. 
LDFR provides an estimate of the amount of verbal information a person is able to encode, 
retain, and retrieve. (4) The CVLT-II also assesses delayed recognition memory through 
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correctly identified items (recognition hits) in a forced-choice yes or no test, presented at the end 
of the test. This forced-choice test consists of all 16 target words from the original list in addition 
to other semantically related and unrelated words. Comparing the recognition hits to false 
positives (intrusions) yields the Recognition Discriminability index.  
 Wechsler Abbreviated Scale of Intelligence (WASI). The WASI was used to estimate 
general cognitive functioning (Wechsler, 1999). It provides an index (FSIQ) of crystallized 
(semantically-based) and fluid (based on online problem-solving) components of cognitive 
functioning and captures the complex coordinated functioning of many brain networks (Benson, 
Hulac, & Kranzler, 2010). The FSIQ score was presented (see Table 1) in order to better describe 
our sample, as recommended by reviewers.  
Neurological Predictor Scale (NPS). The NPS (Micklewright, King, Morris, & 
Krawiecki, 2008) is a brief measure based on medical record reviews. It incorporates information 
about the tumor treatment, and other related neurological sequelae into one cumulative score, 
based on the presence/absence of neurological risk factors (i.e., prescription of seizure 
medications, presence/absence of hydrocephalus and presence/absence of hormone deficiency), 
type of neurosurgery, type of radiation treatment and the presence/absence of chemotherapy. We 
selected it for the current study in order to quantify the cumulative neurological risk within the 
survivor group (see Table 4). 
Procedure 
All participants were tested individually. Survivors and families in the study were 
interviewed to gather information about medical variables, such as age at diagnosis and presence 
of radiation. Medical record review verified these details. Testing typically took place over two 
visits; the first visit lasted approximately 5 hours and the second one lasted approximately 2 
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hours. At the first visit, trained psychology graduate students (under supervision of a licensed 
clinician TZK) administered a medical and developmental history interview, the SCID for DSM-
IV TR Axis I, self-report paper-and-pencil questionnaires, and the CVLT-II as part of a larger 
battery of cognitive tests. The larger battery was designed such that the participants’ memory 
during the 20-minute time delay between the Trial 5 and LDFR trials would not be taxed. The 
CVLT-II was administered during the first 30 minutes of the larger battery, so fatigue effects 
were not of concern. The examiner also checked hearing and mental status of the participant. 
Course credit was given to the undergraduate control participants as per GSU guidelines. The 
researchers compensated adult brain tumor survivors and community controls with $50. At the 
second visit, brain imaging took place in an MRI scanner. A trained MRI technician operated the 
MRI scanner. All participants received $50 compensation for their time and travel at the 
completion of the second visit. 
Study Design and Analyses  
All analyses were conducted using SPSS 17. Values of p< .05 were considered 
statistically significant. Data analyses for each of the aims, including imaging data, involved tests 
of data assumptions to check for extreme values, normality, homogeneity of variance, 
heteroskedasticity, non-independence of residuals, where appropriate. 
We evaluated demographic variables of age, sex, education, and ethnicity as potential 
confounds or potential covariates to be used in analyses (see Table 1). A confound was defined 
as a variable that was significantly different between groups and was also highly correlated with 
outcome (r values with a large effect size). None of the demographic variables met this criteria. 
Additionally, we used a variable as a covariate if that variable emerged as significantly (p<.05) 
and highly correlated (r values with a large effect size) with the dependent variable of interest. 
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Omission of potential covariates has been shown to lead to potential bias in the statistical 
estimates of population parameters (Cohen, Cohen, West, & Aiken, 2003) and including such 
covariates increases precision.  
Sex was significantly and highly correlated with total hippocampal volume (r= -.48, 
p<.001) and total putamen volume (r= -.36, p<.001). Although education was significantly 
correlated with hippocampal volume, the effect size was not large (r=.25, p=.02). Good 
covariates increase power by reducing the error term. However, there is a reduction of power 
when the relationship between the covariate and the dependent variable is not high enough to 
compensate for the loss in degrees of freedom. Therefore, of the demographic variables, only sex 
was included as a covariate for the planned group comparisons of Aim 1. The a priori plan was 
to analyze results with and without co-varying whole brain volume with hippocampus and 
putamen for Aim 1. If whole brain volume emerged as being significantly correlated with any of 
the CVLT-II indices it would be used as a covariate for Aim 3.  
Survivor-specific variables. There are many neurobiological treatment variables that are 
heterogeneous in survivors (e.g., tumor location, tumor type, presence of radiation, 
chemotherapy, and history of hydrocephalus) that could potentially impact the outcomes of 
interest (see Reimers et al., 2003; Scott, Fletcher, & Brookshire, 1998). For a thorough 
description of these survivor-specific variables see Table 1. Larger subsamples of these survivor-
specific variables are needed to address the complexities of these treatment factors on outcomes. 
However, given that 46% of the survivor sample received radiation therapy (n=16) and the 
sample is heterogeneous with regard to their neurobiological and treatment variables, we 
categorized survivors into two subgroups based simply on whether they received cranial 
radiation: survivors who received radiation therapy (RT) and survivors who did not receive 
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radiation therapy (noRT). All survivors in the RT subgroup, but none in the noRT subgroup, had 
received radiation therapy by definition. The mean radiation dose for individuals in the RT group 
was 5409.44±135.20 Gy (Range: 5000 – 5580 Gy). One of these individuals received whole 
brain radiation, five received focal radiation, nine received craniospinal radiation with a boost to 
the tumor site, and one did not have this information about the dose available. 69% of survivors 
in the RT subgroup had received chemotherapy, whereas only 5% of survivors in the noRT 
subgroup had received chemotherapy. More detailed information about the treatment variables 
can be seen in Table 4. We examined effect sizes for differences between these subgroups for all 
analyses, instead of null hypothesis significance testing because of limited sample size.  
We chose to divide the survivor sample based on radiation because the literature provides 
strong support for the deleterious effects of radiation. Evidence for radiation leading to 
pathological processes in the hippocampus has been documented in animal models. Several 
hippocampal changes, including neuro-inflammation and reduction in neurogenesis in pediatric 
rodent brains (Greene-Schloesser et al., 2012), alterations in neuronal function of molecular 
pathways (Greene-Schloesser, Moore, & Robbins, 2013), and alterations in cerebrovasculature 
(Monje, Mizumatsu, Fike, & Palmer, 2002; Monje & Palmer, 2003), occur in response to 
radiation. Ischemic injury in hippocampal regions and white matter is also linked to radiation 
therapy (Tsuruda et al., 1987; Abayomi, 1996).  Moreover, Riggs et al. (2013) provided 
preliminary data at a conference presentation that hippocampal volume is linked to cranial 
radiation for medulloblastoma survivors in a dose-dependent way. Specifically, Riggs et al. 
(2013) found significant group differences when comparing children treated with standard dose 
radiation to those treated with reduced dose and healthy controls. As the study of hippocampal 
structure and function in brain tumor survivors is a focus of the current study, a consideration of 
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potential radiation related damage was required. However, it should be noted that presence of 
radiotherapy is comorbid considerably with other medical factors (e.g., chemotherapy, endocrine 
dysfunction) and therefore interpretations of results should not be linked to radiotherapy alone. 
Therefore, in addition to examining subgroup differences, we examined the correlation of 
volumes with the NPS, which captures the cumulative nature of the treatment variables.  
Group comparisons. In order to evaluate whether survivors differ from healthy controls 
in terms of hippocampal and putamen volume, we used one-way between-groups analysis of 
covariance (ANCOVA), with sex as the covariate. The independent variable was the group 
(survivors, controls), and the dependent variable consisted of volume measurements. We also 
evaluated whether survivors differed from healthy controls in terms of total brain volume, by 
using an ANOVA. In addition, we examined whether group differences in hippocampal and 
putamen volumes persist after controlling for total brain volume by using ANCOVA.  
We used CVLT-II indices to evaluate differences between survivors and controls on 
verbal memory performance, and to determine the nature of verbal memory deficits in the 
survivor group. First, we compared survivors and controls on Trial 1 z scores and on Trial 5 z 
scores. This allowed us to examine whether auditory attention list span and level of learning after 
repeated word-list presentation differed between the two groups. We further evaluated whether 
Trial 5 z scores were significantly different between groups after controlling for Trial 1 z scores. 
This analysis helped us understand whether it was auditory attention list span or the level of 
learning after repeated learning trials that was accounting for differences in the number of words 
learned and recalled by Trial 5. Second, we evaluated whether survivors’ LDFR z scores were 
affected. Then, in order to test whether initial learning or retention was impacting the LDFR z 
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scores, we compared survivors and controls on the LDFR z score after controlling for the Trial 5 
z score. Finally, we compared survivors and controls’ Recognition Discriminability Index z 
scores, as intact recognition in the context of recall deficits would discriminate between encoding 
versus retrieval deficit memory profiles.  
Correlation analysis. Pearson bivariate correlations were obtained to examine the 
association between measures of brain structures and CVLT-II indices of verbal memory 
performance. Brain structures included in the analysis were total hippocampal volume, total 
putamen volume, total brain volume; CVLT-II indices included were Trial 1, Trial 5, LDFR, and 
Recognition Discriminability.  
Results 
For descriptive statistics demonstrating group similarities and differences on the 
dependent variables of interest see Table 2. Overall, group averages for verbal memory abilities 
were within normal limits for most survivors; 60-85% of survivors had scores that were above 
the -1.5 standard deviation clinical cut off from normative means.  
Aim 1: Volumes 
We conducted five separate ANCOVAs that were determined a priori to compare the 
subcortical structures’ and total brain volume of survivors and controls. The independent 
variable was group (survivors, controls) and the dependent variables were measurements of 
hippocampal volume, putamen volume, and total brain volume, respectively. Participants’ sex 
was used as a covariate in all analyses for subcortical structures because it was highly correlated 
with subcortical volumes. After adjusting for sex, there was a significant difference between the 
two groups on measured hippocampal volume (F(1,91)=4.06, p=.047), with a small effect size 
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(ηp2=.04), and a significant difference for putamen volume (F(1,91)=11.18, p=.001), with a 
medium effect size (ηp2=.11) (see Figure 2). Total brain volume also was significantly different 
between the groups (F(1,92)=18.51, p<.01), with a medium effect size (ηp2=.17). For means and 
effect sizes of the noRT and RT treatment subgroups, with regard to group differences in 
volumes, see Table 3.   
We also compared the two groups on their hippocampal and putamen volumes, after 
controlling for total brain volume. There was no statistically significant difference in 
hippocampal volumes between the two groups (F (1,90)=2.26, p=.14, ηp2=.02), after controlling 
for total brain volume. There was a statistically significant difference in putamen volumes 
between the two groups (F (1,90)=9.60, p<.01, ηp2=.10), after controlling for total brain volume.  
Furthermore, we conducted Pearson bivariate correlations for the entire sample to 
examine associations of the subcortical structures and total brain volumes with each other. 
Hippocampus and putamen volumes were significantly correlated (r=.62, p<.001), but neither 
were significantly correlated with total brain volume (r=.09, p=.37; r=.08, p=.45). Associations 
of subcortical structures and total brain volumes displayed a similar pattern for controls and 
survivors, with hippocampus and putamen being significantly correlated (Controls: r=.50, p<.01; 
Survivors: r=.64, p<.01), but neither being significantly correlated with total brain volume (r 
values ranging from -.12 – .13).  
Post-hoc we examined the effects of having received chemotherapy, having a history of 
hydrocephalus, hormone deficiency, and seizure medication. Independent samples t-tests were 
used to compare volumes across these subgroups. Results indicated that survivors who had 
received chemotherapy had significantly lower hippocampal volume (t(33)=-2.52, p=.02, d=-
.90), marginally significantly lower putamen volume (t(33)=-2.06, p=.05, d=-.73), and no 
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significant difference in total brain volume (t(33)=-1.42, p=.16, d=-.51). Individuals who had a 
history of hydrocephalus did not show any significant differences in hippocampal (t(33)=-.33, 
p=.75, d=-.11), putamen (t(33)=-.97, p=.34, d=-.33), or total brain volumes (t(33)=-.68, p=.50, 
d=-.22) . Those who had a hormone deficiency had marginally significantly lower hippocampal 
volume (t(30)=-2.01, p=.05, d=-.72), significantly lower putamen volume (t(30)=-3.07, p=.01, 
d=-1.09), and no significant difference in total brain volume (t(30)=-.92, p=.37, d=-.33) . 
Survivors who were taking seizure medication did not show any significant differences in 
hippocampal (t(31)=.31, p=.76, d=.13), putamen (t(31)=.38, p=71, d=.16), or total brain volumes 
(t(31)=1.02, p=.32, d=.44) . We also explored associations of cumulative neurological risk 
factors on the NPS with subcortical structures and total brain volumes, within the survivor group. 
We found that volumes of the subcortical structures were significantly correlated with NPS 
(Hippocampus: r= -.39, p=.02; Putamen: r= -.46, p<.01), but total brain volume was not 
significantly correlated with NPS (r= -.17, p=.33). 
Aim 2: Verbal Memory  
Initial learning performance. A one-way between groups analysis of variance 
(ANOVA) showed that there was a statistically significant difference in CVLT-II Trials 1 z 
scores (F (1,92)=12.70, p=.001) between the two groups (see Table 2 & Figure 3a). On average, 
survivors scored lower than controls. The actual difference in mean scores between the groups 
was a medium effect size (η2=.12). The performance of 10 survivors (29%) and 7 controls (12%) 
was in the clinically impaired range (i.e., z≤-1.5). A Pearson chi-square test for independence 
with Yates continuity correction was not significant for percent clinically impaired (χ2 (1, 
n=94)= 3.09, p=.08). In other words, survivors’ scores on Trial 1 were statistically lower, and 
rates of clinical impairment displayed a non-significant trend for more impaired participants in 
HIPPOCAMPAL VOLUME AND AUDITORY ATTENTION                                                 23 
 
the survivor group. For means and effect sizes of the noRT and RT treatment subgroups, with 
regard to group differences on Trial 1, see Table 3. 
An ANOVA also showed that there was a statistically significant difference in CVLT-II 
learning Trials 5 z scores (F (1,92)=6.01, p=.02) between the two groups (see Table 2 & Figure 
3a). On average, survivors scored lower than controls. The actual difference in mean scores 
between the groups was a small effect size (η2=.06). For means and effect sizes of the noRT and 
RT treatment subgroups, with regard to group differences, see Table 3. The performance of 14 
survivors (40%) and 7 controls (12%) was in the clinically impaired range (i.e. z≤-1.5). A 
Pearson chi-square test for independence with Yates continuity correction was significant for 
percent clinically impaired (χ2 (1, n=94)=8.47, p=.004). In other words, survivors’ scores were 
statistically lower and more frequently clinically impaired. Because rates of clinical impairment 
were differently represented across the groups for Trial 5, but not Trial 1, we inspected raw 
scores for these trials. We found that from Trial 1 to Trial 5, the increase in number of words 
recalled was the same for survivors and controls (average increase of 6 words). However, the 
distribution of scores for controls was similar at Trial 1 and 5, whereas the distribution of scores 
for survivors doubled in its range from Trial 1 to 5.  
An ANCOVA was conducted to compare the two groups on their Trial 5 z scores, after 
controlling for Trial 1 z scores. The independent variable was group (Survivors, Controls). There 
was no statistically significant difference in adjusted Trial 5 z scores between the two groups (F 
(1,91)=1.03, p=.31, ηp2=.01), after controlling for Trial 1 z scores (see Figure 3b).  
Delayed free recall performance. An ANOVA showed that there was no statistically 
significant difference in CVLT-II LDFR z scores (F (1,92)=3.02, p=.09) between the two groups 
(see Table 2 & Figure 3a). The actual difference in mean scores between the groups was a small 
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effect size (η2=.03). The performance of 7 survivors (20%) and 10 controls (17%) was in the 
clinically impaired range (i.e. z≤-1.5). A Pearson chi-square test for independence with Yates 
continuity correction was not significant for percent clinically impaired (χ2 (1, n=94)=.009, 
p=.93). As such, survivors’ scores were not statistically lower and clinical impairment was not 
differently represented across the groups. For means and effect sizes of the noRT and RT 
treatment subgroups, with regard to group differences in delayed free recall, see Table 3.  
An ANCOVA was conducted to compare the two groups on their CVLT-II LDFR z 
scores, after controlling for Trial 5 z scores. The independent variable was group (Survivors, 
Controls). There was no statistically significant difference in adjusted LDFR z scores between 
the two groups (F (1,91)=.001, p=.97, ηp2<.001), after controlling for Trial 5 z scores (see Figure 
3b). 
Recognition performance. An ANOVA showed that there was no statistically 
significant difference (F (1,91)=3.15, p=.08) in CVLT-II Recognition Discriminability z scores 
between the two groups (see Table 2 & Figure 3a). The actual difference in mean scores between 
the groups was a small effect size (η2=.03). The performance of 5 survivors (15%) and 7 controls 
(12%) was in the clinically impaired range (i.e. z≤-1.5). A Pearson chi-square test for 
independence with Yates continuity correction was not significant for percent clinically impaired 
(χ2 (1, n=93)=.005, p=.94). Therefore, survivors’ scores were not statistically lower and not 
clinically impaired. For means and effect sizes of the noRT and RT treatment subgroups, with 
regard to group differences on recognition, see Table 3. 
Aim 3: Association between Structural Measures and Memory Performance 
For the control group, neither total hippocampal volume, total putamen volume, or total 
brain volume, were significantly correlated with CVLT-II Trial 1, Trial 5, LDFR, or Recognition 
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Discriminability (see Table 5 for r values & Figure 3A). For the survivor group, total 
hippocampal volume emerged as being significantly correlated (r=.43, p=.01) with Trial 1 (see 
Figure 3B), but not with Trial 5, LDFR, or Recognition Discriminability (see Table 5 for r 
values). Total putamen volume and total brain volume were not significantly correlated with 
Trial 1, Trial 5, LDFR, or Recognition Discriminability (see Table 5). Within the survivor 
sample, correlations between total hippocampal volume and total putamen volume were high for 
the noRT (r=.36) and RT (r=.50) subgroups. Furthermore, for the RT subgroup correlations were 
also high for Trial 5, LDFR, and Recognition Discriminability (see Table 5).     
Discussion 
The purpose of our study was to examine verbal memory profiles in adult survivors of 
childhood brain tumor, as well as possible specific correlations of verbal memory with 
hippocampal volume. The current study is among the first to examine differences in hippocampal 
size and verbal memory profiles between long-term adult survivors of childhood brain tumor and 
neurotypical controls. It appears that volumetric differences occur at the level of the whole brain 
as well as specific subcortical structures. Survivors do not exhibit a specific vulnerability of the 
hippocampus. Also, survivors and controls both evidence tight coupling between the volumes of 
subcortical structures, but not between subcortical structures and the whole brain. This lack of 
association between the size of the subcortical structure volumes and the size of the whole brain 
is consistent with the findings of Riggs et al. (2014) in childhood medulloblastoma survivors. 
Furthermore, we were able to describe the specific nature of verbal learning and memory 
performance deficits in adulthood and link those deficits to hippocampus volume. The relevance 
of our findings in the context of past research is discussed.  
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Hippocampal Volume 
Two studies in the research literature have examined the short-term changes that occur in 
hippocampal volume after diagnosis and treatment of a childhood brain tumor. Nagel et al. 
(2004) demonstrated declines until 2 years post-diagnosis in their 5-year longitudinal study of 
medulloblastoma survivors (mean age at diagnosis = 8 years). Likewise, Riggs et al. (2014) 
reported that children with posterior fossa tumors had smaller right hippocampi five years post-
diagnosis and treatment when compared to controls. As predicted, in the current study adult 
survivors (mean age at diagnosis = 8 years) exhibited smaller hippocampi as compared to 
controls on average 15 years post-diagnosis. Thus, early declines in hippocampal volume (Nagel 
et al., 2004; Riggs et al., 2014) are not fully compensated for in later life when child survivors 
grow to become young adults, as evidenced by volumes remaining lower than controls.    
 Of note, even though hippocampal volume was significantly lower for survivors, a 
similar pattern was also observed for the putamen and whole brain volumes. In fact, the effect 
sizes for differences between survivors and controls in putamen and whole brain volumes were 
medium in magnitude, whereas the effect size of the hippocampus was small in magnitude.  
Furthermore, after controlling for whole brain volume, the differences in hippocampal volume 
were no longer significant. These findings highlight the importance of using control structures 
and total brain volume in neuropsychological studies of brain tumor survivors. As noted by 
Riggs et al. (2014), many neuroimaging studies (e.g., Nagel et al., 2004) report only change in 
raw hippocampal size, making it impossible to ascertain a particular structure’s vulnerability and 
inter-relationships among different brain regions.  
One possible conclusion from these findings is that disruption to brain development for 
survivors is more global in nature and that the hippocampus is not more vulnerable, despite 
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putative accounts of its higher metabolic needs. However, a closer review of the means and 
effect sizes of survivor subgroups (i.e., RT and noRT) indicates that treatment may affect 
subcortical structures differently than the remaining brain parenchyma (see Table 3). 
Specifically, the volumes for subcortical structures (i.e., hippocampus and putamen) of the noRT 
subgroup are similar to those of controls, with the RT subgroup showing the largest effect sizes; 
whereas the whole brain volume of the RT and noRT subgroups are similar, with the control 
group showing the largest effect size. Together, these findings indicate that simply having a brain 
tumor is associated with having a lower total brain volume, regardless of other medical variables. 
However, greater medical complexity is associated with having lower volumes with regard to 
subcortical structures. In other words, cumulative neurological risk factors appear to have a 
unique effect on subcortical structures.  
 Given that cumulative neurological risk factors affect the volume of subcortical structures 
differently than whole brain volume, we examined the effects of having received chemotherapy, 
having a history of hydrocephalus, hormone deficiency, and seizure medication. These individual 
exploratory analyses detected the importance of chemotherapy and hormone deficiency with 
regard to hippocampal and putamen volumes. This is consistent with significant NPS 
correlations with hippocampus and putamen volumes. There appeared to be no effect of having a 
history of hydrocephalus or seizure medication on any of the volumes. There are two things of 
note with regard to these analyses: (1) Presence of chemotherapy is confounded with presence of 
radiation, as all individuals who received chemotherapy, except one, also received radiation (see 
Table 4); (2) Hormone deficiency in our sample typically co-occurs with other diagnostic and 
treatment variables (e.g., craniopharyngioma, medulloblastoma, radiotherapy) (see Table 4). As 
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such, these effects may not be a product of simply chemotherapy drugs or endocrine dysfunction, 
but rather are a product of complex neurological health factors. 
Verbal Memory 
Although no existing research has tested verbal memory profiles in long-term (>15 years 
since diagnosis) adult survivors of pediatric brain tumor, some short-term childhood studies 
(King et al., 2004; Micklewright et al., 2007; Nagel et al., 2006) and some adult studies 
(Armstrong et al., 2001; Ellenberg et al., 2009) suggest memory difficulties in the context of 
brain tumor survivorship. Building upon previous research findings, we found that performance 
scores for auditory attention list span, as well as level of learning after repeated word-list 
presentation, are significantly poorer in adult survivors of childhood brain tumor, compared to 
controls. Previous research in children with third ventricle and cerebellar tumors has documented 
elevated attentional problems, as measured by Trial 1 of a list learning task (Micklewright et al., 
2007; Papazoglou, King, Morris, Morris, & Krawiecki, 2008), and our data show that auditory 
attentional impairments extend into adulthood. As shown by another childhood study, poor 
attention is associated with lower adaptive functioning (Papazoglou et al., 2008) and could place 
our adult survivors at risk for deficits in daily living skills compared to their neurotypical peers.  
Our findings of poorer auditory attention list span in the context of a verbal memory task 
are also consistent with the verbal memory findings reported for child medulloblastoma 
survivors by Nagel et al. (2006). In contrast to our results that delayed free recall and recognition 
are not significantly different between survivors and controls, Nagel et al. (2006) found that 
performance scores for delayed recall and recognition were significantly lower. These findings 
relative to those of the current study may be explained by methodological differences across the 
studies. First, their memory profiles are based on the California Verbal Learning Test for 
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children (CVLT-C) as they were testing a child sample (Age at testing M=9.34±3.10), whereas 
the current study data are based on the CVLT-II in an adult sample (Age at testing 
M=24.10±4.93). Second, they administered the test 0-30 months after diagnosis, and 70% of the 
children in their study were receiving treatment at the time of testing. In contrast, we 
administered the test 5-24 years after diagnosis, and none of the adults in our study were 
receiving treatment. Third, their sample included only medulloblastoma survivors, whereas ours 
is a heterogeneous sample. The different verbal memory profile captured by the long-term 
approach of our study suggests that future research should follow memory outcomes for a period 
of time that is, on average, greater than 10 years in pediatric survivors with a variety of tumor 
types. Such research will further improve our understanding of the development of memory 
abilities in this population.  
Critically, with regard to the memory profiles demonstrated in our sample, differences 
between the amount of material learned after repeated presentation (i.e, Trial 5) seemed to be 
largely contingent upon the initial auditory attention list span; level of learning was not 
significantly different between the two groups after controlling for auditory attention list span. 
Likewise, delayed recall was not significantly different. Interpreted as a whole, this pattern of 
findings suggests that the rate of learning (i.e., number of new words gained at each trial) and 
level of retention (i.e., amount of learned information that is maintained in memory) are 
relatively intact. If the rate of learning and level of retention were critical factors differentiating 
the verbal memory abilities of survivors and controls, then we would have seen significant 
differences in later memory trials after controlling for performance at earlier trials.  
Furthermore, survivors’ scores with regard to clinical impairment (i.e., z≤ -1.5) on Trial 1 
were not differently represented across the groups, but on Trial 5 significantly more survivors’ 
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than controls’ scores were in the clinically impaired range. An examination of raw scores 
showed that the average number of words gained from Trial 1 to Trial 5 was similar for survivors 
and controls, but the distribution of scores at each of those times points was different. One 
potential reason for differences in level of clinical impairment across Trials 1 and 5 is that some 
survivors’ performance showed only small gains from repetition, but others showed large gains. 
These findings highlight the importance of examining levels of clinical impairment, in addition 
to group means.  
Brain Structure and Memory Function Relationships 
The third aim of our study was to examine whether or not the hippocampus is associated 
with performance on verbal learning and memory. Building upon the existing brain tumor 
research on verbal memory, hippocampal volume of the survivors was found to be significantly 
correlated to auditory attention list span, in the context of a verbal memory task. Furthermore, 
larger hippocampal volumes of the RT and noRT subgroups were associated with higher scores 
on CVLT-II Trial 1. Our confidence in the specificity of our findings is increased by the fact that 
we did not find a significant correlation between putamen volume of survivors and any of the 
verbal memory indices, despite putamen volumes being highly correlated with hippocampal 
volumes. Consistent with prior studies (e.g., Riggs et al., 2014), whole brain volume of the 
survivors was not significantly correlated with any of the memory indices. As such, it appears 
that the reductions in auditory attention list span scores are specifically associated with reduced 
hippocampal volume and the deficits in other structures do not contribute to the auditory 
attention aspect of verbal memory function. 
In addition, for the control group, there was no relationship between hippocampal volume 
and any of the verbal memory indices. This finding is consistent with Van Petten et al.’s (2004) 
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account that “bigger” is not always “better”. Based on a meta-analysis, their account posits that 
in neurologically intact adults the “bigger is better” explanation of regional structure-function 
relationships may be too simplistic, because size reveals little about relative proportions of 
neurons and astrocytes, synaptic densities, ratios of excitatory to inhibitory synapses, and 
patterns of synaptic connectivity. 
The current study’s finding of the association between hippocampal volume and auditory 
attention list span has not been hypothesized in the existing research on childhood brain tumors. 
There are two potential explanations for our unique findings: (1) The association between these 
constructs may be unique to adult survivors of childhood brain tumor because their brains were 
developing at the time of diagnosis and treatment. (2) Other studies linking the hippocampus to 
verbal memory do not scrutinize components of the memory system of their sample in this 
manner. As such, it is difficult to comment on whether or not the hippocampus plays a role in the 
auditory attention span aspect of verbal memory function in these studies. Although poorer 
verbal learning has been shown to be related to smaller hippocampus size in various patient 
populations, our study demonstrates that this relationship extends to auditory attention span 
aspects of learning for adult survivors of childhood brain tumor. Historically, the declarative 
memory system has consistently been shown to depend on a network of structures within the 
medial temporal lobe (MTL) and the prefrontal cortex, with which the MTL interacts (Reber et 
al., 2002; Simons & Spiers, 2003; Squire, 2004; Squire, Stark, & Clark, 2004; Tulving & 
Markowitsch, 1998). Within the MTL-based memory networks, the hippocampus is believed to 
be a central structure (Tulving & Markowitsch, 1998). Ample research shows that it is heavily 
involved in the execution of declarative memory functions (for a review, see Squire, 1992, 2004; 
Squire et al., 2004). Specifically, the hippocampus consolidates, or binds together, information 
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about objects and events (Bucci & Robinson, 2014). In addition, it mediates elemental cognitive 
processes (i.e., associative representation, sequential organization, and relational networking), 
beginning with the learning stage and continuing on to consolidation over a prolonged period of 
time (Eichenbaum, 2004). Finally, research using intracranial recordings of cognitive potentials 
indicates that the hippocampus also participates in the recall of information (Grunwald, 2008). 
However, in recent years, animal models and functional neuroimaging research findings have 
called into question the assumption that the hippocampus plays a primary role in memory. 
Indeed, the “best” characterization of functions associated with specific MTL regions remains a 
matter of debate (Moscovitch, 2008); there is still much unknown about the precise contributions 
to memory of the hippocampus. As research on the declarative memory system continues, it is 
possible that the historical account of the hippocampus being primarily responsible for memory 
performance will prevail; but it is also possible that our knowledge about the role of the 
hippocampus will evolve.   
Limitations and Future Directions 
As participants were recruited through large mailings inviting individuals to participate, 
selection bias must be considered regarding these results and their limitations. For detailed 
information on the number of survivors included and retention rates see the Appendix. It is 
possible that individuals chose to participate in the study because cognitive problems were 
salient. Alternatively, it may be that survivors with fewer cognitive concerns were more able to 
participate because of higher levels of independence. Given the large proportion of survivors 
who performed within normal limits on the verbal memory task, it is possible that this sample is 
higher functioning than survivors who did not participate. In addition, because the current study 
allowed for the recruitment of a survivor group with varied tumor pathologies (i.e., tumor type 
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and location) the study design does not have the ability to specify the effects of particular tumor 
types or locations. Therefore, all interpretations and clinical recommendations that could emerge 
from the current research should be considered in these contexts.  
Another limitation is the study’s inability to conduct MRI scans on some individuals in 
the study sample (see the Appendix): (1) Individuals with certain types of metal in their skull or 
body and/or certain medical devices implanted at the time of surgery (e.g., shunts which create 
artefact or pose a safety risk in the scanner). Although most present day neurological devices are 
MRI-safe, exact specifications of type of device, manufacturer name, and serial number are 
essential in order to determine safety. These devices, when deemed unsafe for MRI, or in the 
absence of sufficient information about implanted devices, prevented the acquisition of 
neuroimaging data; (2) Survivors lost to follow-up; (3) Individuals who declined to participate in 
the imaging component of the study. Thus, survivors who met criteria for MRI safety, as well as 
those who remained in contact to attend the imaging visit, may represent a “better outcome” 
group. As such, findings may not generalize to survivors with medical devices and to those who 
we were unable to follow-up.  
To this end, we examined the CVLT-II scores for the individuals who met the eligibility 
criteria for the study and had completed cognitive testing but did not have imaging data 
available. We found that the CVLT-II mean scores for this no MRI survivor group were 
significantly lower on Trial 5 (M=-1.40±1.15; t(64)=-2.19, p=.03, d=-.54) and LDFR (M=-
1.39±1.09; t(64)=-2.81, p=.01, d=-.70), but not Trial 1 (M=-1.08±.80; t(64)=-1.54, p=.13, d=-.38) 
and Recognition Discriminability (M=-.92±1.48; t(63)=-1.85, p=.07, d=-.46), than the means of 
those included in the study (see Table 2). These differences in memory performance between 
survivors who were unable to participate in the neuroimaging component of the study and 
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survivors who were able to participate illustrate that we must be cautious when interpreting the 
findings about cognitive outcomes from the current and other neuroimaging studies. Also, if such 
studies have additional cognitive data available it is helpful to report these data so that readers 
know more about the generalizability of their findings. Our results suggest that memory deficits 
are more pronounced, on average, in the no MRI survivor group. It is possible that more robust 
relationships between performance and brain volumes may be identified with the inclusion of 
these individuals. 
Given our findings of the prominent role of CVLT-II auditory attention list span, a 
limitation of the study is that there was no diagnostic information available for Attention Deficit 
Hyperactivity Disorder (ADHD). Therefore, concerns that their attentional functioning may 
impact CVLT-II Trial 1 performance cannot be addressed. We excluded control participants with 
a self-reported history of developmental conditions, such as diagnosis of ADHD. And although 
the SCID – Axis I was administered, unfortunately, it does not assess for a diagnosis of ADHD.  
Obtaining detailed information about ADHD symptoms could be particularly important for 
future studies, to determine if survivors meet full criteria for ADHD and whether any 
participants were on medication for attention problems.  
As survival rates for childhood brain tumors continue to be maintained and improved, 
describing the specific patterns of verbal memory abilities or deficits, in adult survivors of 
childhood brain tumor is an important endeavor. Results from our study may inform the 
development of interventions focused on improving attention and cognitive performance (see 
Castellino, Ullrich, Whelen, & Lange, 2014). Studies may explore the efficacy of various clinical 
recommendations for neurocognitive rehabilitation, including home-based computerized 
protocols that are starting to show some promise for improving memory and attention (Castellino 
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et al., 2014). For example, one recommendation would be to provide survivors with multiple 
formats (i.e., auditory + visual) of the material to be learned in order to boost the initial encoding 
of that material. Another recommendation would be to provide multiple opportunities to learn the 
material and a longer time frame to learn new content, as this may allow them to eventually 
encode the same amount of total material as a neurotypical adult.  
Posterior regions of the hippocampus have been implicated as being more vulnerable in 
individuals with cerebellar tumors due to a treatment regimen that includes whole brain 
radiation, as well as a boost to the posterior fossa (see Nagel et al., 2004). At least one functional 
MRI study of neurotypical adults has shown that the posterior part of the hippocampus is 
engaged in verbal encoding during a word-list learning paradigm (Fernandez et al., 1998). 
Together, these studies indicate that there may be a specific link between posterior regions of the 
hippocampus and encoding of verbal material. Manually delineating the posterior region of the 
hippocampus for volumetric analysis could be a useful next step.   
Finally, lateralization of hippocampal function with regard to verbal versus visual 
memory has been reported in the adult literature (de Toledo-Morrell et al., 2000; Milner, 1971; 
Kelley et al., 1998; Ystad et al., 2009), with the left hippocampus being sensitive to verbal 
material. However, generalizing these adult findings to developing populations is problematic. 
Helmstaedter & Elger (2009) have shown that only the mature brain shows left/right temporal 
lobe differences in verbal memory and that such lateralization is not evident in children or the 
elderly. Our current data show that, on average, the left and right hippocampi each have lower 
volumes in survivors compared to controls (see Table 2), with the left being significantly lower 
and more vulnerable (F(1,91)=5.42, p=.02, ηp2=.06). The pattern of findings with regard to the 
association of left and right hippocampi to total brain volume, as well as their association to 
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verbal memory measures, are the same for all analyses conducted in the study. These findings 
suggest that both left and right hippocampal volumes are associated with auditory attention list 
span and learning on Trial 1 of CVLT-II.  Future studies should consider expanding upon these 
findings by exploring white matter integrity of specific memory and attention pathways using 
diffusion tensor imaging tractography (e.g., Brewster, King, Burns, Drossner, & Mahle, in press; 
Law, Bouffet, & Laughlin, 2011; Smith, King, Jayakar, & Morris, 2014).   
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Table 1. Demographic, diagnostic, and treatment variables 
Demographic Variables Survivors (n=35) Controls (n=59) 
Female (n, %) 19 (54%) 32 (54%) 
Education (mean ± SD)* 13.57 ± 1.88 14.39 ± 1.67 
Age at testing (mean ± SD) 24.10 ± 4.93 22.40 ± 4.35 
   Range 17-36 18-41 
Ethnicity (n, %)*   
   Caucasian 27 (77%) 26 (46%) 
   African-American 5 (14%) 18 (32%) 
   Other‡ 3 (9%) 13 (23%) 
SES§ 
   Range 
   Financially dependent 
2.32 ± 1.20 
1-5 
18 (51%) 
2.86 ± 1.44 
1-5 
36 (61%) 
WASI Full Scale IQ (FSIQ)* 101.82 ± 16.28 109.86 ± 10.32 
 
  
Diagnostic & Treatment Variables   
Years post diagnosis (mean ± SD) 
 Range 
15.38 ± 5.34 
5 – 24 
 
 Median 16.21  
Age at diagnosis (mean ± SD) 
 Range 
8.17 ± 4.43 
1 – 17 
 
 Median 9.00  
Tumor location (n, %)   
   Posterior fossa 20 (57%)  
   Pituitary 6 (17%)  
   Frontal lobe 3 (9%)  
   Temporal lobe 3 (9%)  
   Other^ 3 (9%)  
Tumor type (n, %)   
   Astrocytoma 10 (29%)  
   Medulloblastoma 9 (26%)  
   Craniopharyngioma 5 (14%)  
   Ganglioglioma 3 (9%)  
   Other†  8 (23%)  
Radiation (n, %) 16 (46%)  
Chemotherapy (n, %) 12 (34%)  
History of hydrocephalus (n, %) 16 (46%)  
History of seizure medication (n, %) 7 (20%)  
Hormone deficiency (n, %) 15 (43%)  
Note. *Significantly different between groups at p=.05; independent samples t-test for education, age, 
SES, and FSIQ; chi-square test for sex, ethnicity, and financial dependence.  
^1 Parietal, 1 Occipital, 1 Thalamus.  
†1 PNET, 2 Glioma, 1 Mixed Astrocytoma and Teratoma, 1 Meningioma, 1 Mixed germ cell, 1 Choroid 
plexus papilloma, 1 Cerebral neuroblastoma  
‡.Survivors: 1 Asian, 1 Hispanic, 1 Mixed; Controls: 7 Asian, 5 Hispanic, 1 Mixed. . §SES = Current 
socioeconomic status, estimated using the Hollingshead Four Factor Index of Social Status (Hollingshead, 
1975). Family SES was used for cases where the individual was financially dependent and individual SES 
was used for cases where the individual was financially independent. 
HIPPOCAMPAL VOLUME AND AUDITORY ATTENTION                                                 48 
 
Table 2. Comparison of outcome variables for the two groups  
 Survivors (n=35) 
Mean ± SD 
Controls (n=59) 
Mean ± SD 
Volume   
Total Hippocampus*  7.56 ± 1.01 7.91 ± .89 
Left Hippocampus* 3.70 ± .58 3.93 ± .49 
Right Hippocampus 3.86 ± .60 3.98 ± .51 
Total Putamen* 9.88 ± 1.21 10.63 ± 1.09 
Whole Brain Volume* 1544.00 ± 63.00 1597.60 ± 55.41 
CVLT-II   
   List A Trial 1 z score* 
 Number Impaired (%) 
-.80 ± .69 
10 (29%) 
-.07 ± 1.09 
7 (12%) 
   List A Trial 5 z score* 
 Number Impaired (%)* 
-.73 ± 1.33 
14 (40%) 
-.11 ± 1.09 
7 (12%) 
   Long Delay Free Recall z score 
 Number Impaired (%) 
-.57 ± 1.25 
7 (20%) 
-.14 ± 1.13 
10 (17%) 
   Recognition Discriminability Index z score 
 Number Impaired (%) 
-.34 ± 1.03 
5 (15%) 
.05 ± 1.01 
7 (12%) 
Note. *Significantly different between groups at p=.05. Volumes are reported in cubic 
centimeters. Impaired: z≤ -1.5 
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Table 3. Means and effect sizes for treatment subgroups.  
 Mean ± SD Subgroup Difference Effect Sizes 
 RT (n=16) noRT (n=19) Controls (n=59) RT vs. noRT RT vs. Control noRT vs. Control 
Hippocampal Volume 7.28 ± .89 7.80 ± 1.07 7.91 ± .89 -.52 -.71 -.12 
Putamen Volume 9.25 ± 1.00 10.41 ± 1.14 10.63 ± 1.09 -1.08 -1.29 -.20 
Brain Volume 1541.70 ± 70.58 1546.00 ± 57.76 1597.60 ± 55.41 -.07 -.95 -.92 
Trial 1 -.91 ± .66 -.71 ± .71 -.07 ± 1.09 -.29 -.83 -.63 
Trial 5 -.44 ± 1.30 -.97 ± 1.34 -.11 ± 1.09 .40 -.29 -.75 
LDFR -.56 ± 1.34 -.58 ± 1.20 -.14 ± 1.13 .02 -.36 -.38 
Recognition -.28 ± .86 -.39 ± 1.18 .05 ± 1.01        .11         -.34 -.42 
Note. Effect sizes reported are Cohen’s d. RT: Survivors who received radiation therapy; noRT: Survivors who did not receive 
radiation therapy.  
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Table 4. Diagnostic and treatment variables in survivor subgroups  
Diagnostic & Treatment Variables RT (n=16) noRT (n=19) 
Female (n, %) 9 (56%) 10 (53%) 
Education (mean ± SD) 13.00 ± 1.21 14.05 ± 2.22 
Age at testing (mean ± SD) 
            Range 
24.01 ± 4.42 
18-32 
24.17 ± 5.44 
17-36 
Tumor type (n, %)* 
 Medulloblastoma 
            Craniopharyngioma 
 Astrocytoma 
            Ganglioglioma 
 
9 (56%) 
4 (25%) 
1 (6%) 
0 (0%) 
 
1 (5%) 
1 (5%) 
10 (53%) 
3 (16%) 
Tumor location (n, %) 
             Cerebellum/Post. fossa 
             Pituitary 
             Temporal lobe 
 
7 (44%) 
5 (31%) 
0 (0%) 
 
11 (58%) 
1 (5%) 
3 (16%) 
Years post diagnosis (mean ± SD) 
 Range 
15.64 ± 4.62 
5 - 23 
15.16 ± 6.00 
6 - 24 
Age at diagnosis (mean ± SD) 
 Range 
7.56 ± 3.81 
1 - 16 
8.68 ± 4.93 
1 - 17 
Radiation (n, %)* 16 (100%) 0 (0%) 
Chemotherapy (n, %)* 11 (69%) 1 (5%) 
History of hydrocephalus (n, %) 7 (44%) 9 (47%) 
History of seizure medication (n, %) 1 (6.3%) 6 (32%) 
Hormone deficiency (n, %)* 13 (81%) 2 (11%) 
NPS Score (median)* 
            Range 
8 
5-9 
4 
2-6 
Note. *Significantly different between groups at p<.05. RT: Survivors who received radiation 
therapy; noRT: Survivors who did not receive radiation therapy. NPS: Neurological Predictor 
Scale (Micklewright et al., 2008); a brief measure based on medical record reviews that 
incorporates information about the tumor treatment, and other related neurological sequelae into 
one cumulative score 
 
Table 5. Correlations between brain structure volumes and verbal memory indices 
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 Hippocampus Putamen Whole 
Brain 
Trial 1 Trial 5 LDFR Recognition 
Controls (n=59)        
Hippocampus 1 .50* -.06 .13 .15 .11 .08 
Putamen  -- 1 -.12 -.02 .13 .09 .02 
Whole Brain  -- -- 1 .03 .10 .11 .13 
Survivors (n=35)        
Hippocampus 1 .64* .13 .43* .06 .12 -.02 
Putamen  -- 1 .03 .05 -.04 .03 .01 
Whole Brain  -- -- 1 .12 -.09 -.15 -.12 
noRT (n=19)        
Hippocampus 1 .73* .19 .36 -.11 -.25 -.27 
Putamen  -- 1 .24 .01 -.01 .04 .03 
Whole Brain  -- -- 1 -.01 -.16 -.38 -.29 
RT (n=16)        
Hippocampus 1 .41 .07 .50* .46* .62* .51* 
Putamen  -- 1 -.24 -.07 .17 .04 .07 
Whole Brain  -- -- 1 .24 -.03 .05 .09 
Note. *Significant at p<.05 (one-tailed). RT: Survivors who received radiation therapy; noRT: 
Survivors who did not receive radiation therapy.  
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Figure 1. MRI-based example of FIRST segmentation. (a) Yellow and red regions represent 
right and left hippocampi. (b) Yellow and red regions represent right and left putamens.  
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Figure 2. Total hippocampal and putamen volumes. *Indicates significant difference at p=.05. 
Error bars represent standard error. BT: Brain tumor survivors 
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B  
Figure 3. A) Unadjusted performance on select indices of the CVLT-II. B) Adjusted 
performance (ANCOVA) on select indices of the CVLT-II. *Indicates significant difference at 
p=.05. Error bars represent standard error. Means shown are estimated marginal means (except 
Trial 1).  LDFR=Long Delay Free Recall. RD=Recognition Discriminability. BT: Brain tumor 
survivors 
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Figure 3. Scatterplots: A) Control group B) Survivor group. Volume are in cubic millimeters.  
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Total letters sent for 
parent study
n=670
Total calls received
n=121
Cognitive testing 
completed for parent 
study 
n=95
Met initial inclusion 
criteria for current study
n=76
Received neuroimaging
n=43
Included in the study 
n=35
Neuroimaging exclusion
n=8
Poor brain segmentation
n=3
Poor brain registration 
n=5
Excluded because of no 
imaging
n=32
Not interested
n=5
MRI-safety
n=8
Lost to follow-up
n=19
Deceased
n=1
Excluded from initial 
study
n=19
Age (<17 y/o)
n=5
NF, PDD
n=4
Visual impairment
n=3
Comorbid neurological 
conditions
n=3
Severe hearing 
difficulties 
n=2
no CVLT-II data available
n=2
Drop out 
n=26
Undelivered Letters
n=88
Appendix 
Survivor Recruitment 
